Sodium Zirconium Cyclosilicate (ZS) 5g

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Hyperkalemia

Phase 2

ZS Ph2/3 Dose-response Study in Japan

CompletedNCT03127644

AstraZenecaHyperkalemia

Start: 2017-06-14End: 2018-02-23Updated: 2019-05-20

Phase 3

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia

CompletedNCT02875834

AstraZenecaHyperkalemia

Start: 2017-03-03End: 2018-02-14Updated: 2020-08-19

Related Papers

A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia

Clinical and Experimental Nephrology2020-10-2417 citations

Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study.

2020-08-109 citations